Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study

Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups. We evaluated the vaccine effectiveness (VE) of PPV23 against vaccine-type pneumococcal pneumonia in a cohort of ad...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS medicine 2020-10, Vol.17 (10), p.e1003326-e1003326
Hauptverfasser: Lawrence, Hannah, Pick, Harry, Baskaran, Vadsala, Daniel, Priya, Rodrigo, Chamira, Ashton, Deborah, Edwards-Pritchard, Rochelle C, Sheppard, Carmen, Eletu, Seyi D, Litt, David, Fry, Norman K, Rose, Samuel, Trotter, Caroline, McKeever, Tricia M, Lim, Wei Shen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!